Detecting Dysglycemia Using the 2015 United States Preventive Services Task Force Screening Criteria: A Cohort Analysis of Community Health Center Patients.

<h4>Background</h4>In 2015, the United States Preventive Services Task Force (USPSTF) recommended targeted screening for prediabetes and diabetes (dysglycemia) in adults who are aged 40 to 70 y old and overweight or obese. Given increasing prevalence of dysglycemia at younger ages and lo...

Full description

Saved in:
Bibliographic Details
Main Authors: Matthew J O'Brien, Ji Young Lee, Mercedes R Carnethon, Ronald T Ackermann, Maria C Vargas, Andrew Hamilton, Nivedita Mohanty, Sarah S Rittner, Jessica N Park, Amro Hassan, David R Buchanan, Lei Liu, Joseph Feinglass
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-07-01
Series:PLoS Medicine
Online Access:https://journals.plos.org/plosmedicine/article/file?id=10.1371/journal.pmed.1002074&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849765337593020416
author Matthew J O'Brien
Ji Young Lee
Mercedes R Carnethon
Ronald T Ackermann
Maria C Vargas
Andrew Hamilton
Nivedita Mohanty
Sarah S Rittner
Jessica N Park
Amro Hassan
David R Buchanan
Lei Liu
Joseph Feinglass
author_facet Matthew J O'Brien
Ji Young Lee
Mercedes R Carnethon
Ronald T Ackermann
Maria C Vargas
Andrew Hamilton
Nivedita Mohanty
Sarah S Rittner
Jessica N Park
Amro Hassan
David R Buchanan
Lei Liu
Joseph Feinglass
author_sort Matthew J O'Brien
collection DOAJ
description <h4>Background</h4>In 2015, the United States Preventive Services Task Force (USPSTF) recommended targeted screening for prediabetes and diabetes (dysglycemia) in adults who are aged 40 to 70 y old and overweight or obese. Given increasing prevalence of dysglycemia at younger ages and lower body weight, particularly among racial/ethnic minorities, we sought to determine whether the current screening criteria may fail to identify some high-risk population subgroups.<h4>Methods and findings</h4>We investigated the performance of the 2015 USPSTF screening recommendation in detecting dysglycemia among US community health center patients. A retrospective analysis of electronic health record (EHR) data from 50,515 adult primary care patients was conducted. Longitudinal EHR data were collected in six health centers in the Midwest and Southwest. Patients with a first office visit between 2008 and 2010 were identified and followed for up to 3 y through 2013. We excluded patients who had dysglycemia at baseline and those with fewer than two office visits during the follow-up period. The exposure of interest was eligibility for screening according to the 2015 USPSTF criteria. The primary outcome was development of dysglycemia during follow-up, determined by: (1) laboratory results (fasting/2-h postload/random glucose ≥ 100/140/200 mg/dL [5.55/7.77/11.10 mmol/L] or hemoglobin A1C ≥ 5.7% [39 mmol/mol]); (2) diagnosis codes for prediabetes or type 2 diabetes; or (3) antidiabetic medication order. At baseline, 18,846 (37.3%) participants were aged ≥40 y, 33,537 (66.4%) were overweight or obese, and 39,061 (77.3%) were racial/ethnic minorities (34.6% Black, 33.9% Hispanic/Latino, and 8.7% Other). Overall, 29,946 (59.3%) patients had a glycemic test within 3 y of follow-up, and 8,478 of them developed dysglycemia. Only 12,679 (25.1%) patients were eligible for screening according to the 2015 USPSTF criteria, which demonstrated the following sensitivity and specificity (95% CI): 45.0% (43.9%-46.1%) and 71.9% (71.3%-72.5%), respectively. Racial/ethnic minorities were significantly less likely to be eligible for screening yet had higher odds of developing dysglycemia than whites (odds ratio [95% CI]: Blacks 1.24 [1.09-1.40]; Hispanics 1.46 [1.30-1.64]; and Other 1.33 [1.16-1.54]). In addition, the screening criteria had lower sensitivity in all racial/ethnic minority groups compared to whites. Limitations of this study include the ascertainment of dysglycemia only among patients with available test results and findings that may not be generalizable at the population level.<h4>Conclusions</h4>Targeted diabetes screening based on new USPSTF criteria may detect approximately half of adult community health center patients with undiagnosed dysglycemia and proportionately fewer racial/ethnic minorities than whites. Future research is needed to estimate the performance of these screening criteria in population-based samples.
format Article
id doaj-art-866db47f1bae44369b73d1cf9dca5edc
institution DOAJ
issn 1549-1277
1549-1676
language English
publishDate 2016-07-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Medicine
spelling doaj-art-866db47f1bae44369b73d1cf9dca5edc2025-08-20T03:04:53ZengPublic Library of Science (PLoS)PLoS Medicine1549-12771549-16762016-07-01137e100207410.1371/journal.pmed.1002074Detecting Dysglycemia Using the 2015 United States Preventive Services Task Force Screening Criteria: A Cohort Analysis of Community Health Center Patients.Matthew J O'BrienJi Young LeeMercedes R CarnethonRonald T AckermannMaria C VargasAndrew HamiltonNivedita MohantySarah S RittnerJessica N ParkAmro HassanDavid R BuchananLei LiuJoseph Feinglass<h4>Background</h4>In 2015, the United States Preventive Services Task Force (USPSTF) recommended targeted screening for prediabetes and diabetes (dysglycemia) in adults who are aged 40 to 70 y old and overweight or obese. Given increasing prevalence of dysglycemia at younger ages and lower body weight, particularly among racial/ethnic minorities, we sought to determine whether the current screening criteria may fail to identify some high-risk population subgroups.<h4>Methods and findings</h4>We investigated the performance of the 2015 USPSTF screening recommendation in detecting dysglycemia among US community health center patients. A retrospective analysis of electronic health record (EHR) data from 50,515 adult primary care patients was conducted. Longitudinal EHR data were collected in six health centers in the Midwest and Southwest. Patients with a first office visit between 2008 and 2010 were identified and followed for up to 3 y through 2013. We excluded patients who had dysglycemia at baseline and those with fewer than two office visits during the follow-up period. The exposure of interest was eligibility for screening according to the 2015 USPSTF criteria. The primary outcome was development of dysglycemia during follow-up, determined by: (1) laboratory results (fasting/2-h postload/random glucose ≥ 100/140/200 mg/dL [5.55/7.77/11.10 mmol/L] or hemoglobin A1C ≥ 5.7% [39 mmol/mol]); (2) diagnosis codes for prediabetes or type 2 diabetes; or (3) antidiabetic medication order. At baseline, 18,846 (37.3%) participants were aged ≥40 y, 33,537 (66.4%) were overweight or obese, and 39,061 (77.3%) were racial/ethnic minorities (34.6% Black, 33.9% Hispanic/Latino, and 8.7% Other). Overall, 29,946 (59.3%) patients had a glycemic test within 3 y of follow-up, and 8,478 of them developed dysglycemia. Only 12,679 (25.1%) patients were eligible for screening according to the 2015 USPSTF criteria, which demonstrated the following sensitivity and specificity (95% CI): 45.0% (43.9%-46.1%) and 71.9% (71.3%-72.5%), respectively. Racial/ethnic minorities were significantly less likely to be eligible for screening yet had higher odds of developing dysglycemia than whites (odds ratio [95% CI]: Blacks 1.24 [1.09-1.40]; Hispanics 1.46 [1.30-1.64]; and Other 1.33 [1.16-1.54]). In addition, the screening criteria had lower sensitivity in all racial/ethnic minority groups compared to whites. Limitations of this study include the ascertainment of dysglycemia only among patients with available test results and findings that may not be generalizable at the population level.<h4>Conclusions</h4>Targeted diabetes screening based on new USPSTF criteria may detect approximately half of adult community health center patients with undiagnosed dysglycemia and proportionately fewer racial/ethnic minorities than whites. Future research is needed to estimate the performance of these screening criteria in population-based samples.https://journals.plos.org/plosmedicine/article/file?id=10.1371/journal.pmed.1002074&type=printable
spellingShingle Matthew J O'Brien
Ji Young Lee
Mercedes R Carnethon
Ronald T Ackermann
Maria C Vargas
Andrew Hamilton
Nivedita Mohanty
Sarah S Rittner
Jessica N Park
Amro Hassan
David R Buchanan
Lei Liu
Joseph Feinglass
Detecting Dysglycemia Using the 2015 United States Preventive Services Task Force Screening Criteria: A Cohort Analysis of Community Health Center Patients.
PLoS Medicine
title Detecting Dysglycemia Using the 2015 United States Preventive Services Task Force Screening Criteria: A Cohort Analysis of Community Health Center Patients.
title_full Detecting Dysglycemia Using the 2015 United States Preventive Services Task Force Screening Criteria: A Cohort Analysis of Community Health Center Patients.
title_fullStr Detecting Dysglycemia Using the 2015 United States Preventive Services Task Force Screening Criteria: A Cohort Analysis of Community Health Center Patients.
title_full_unstemmed Detecting Dysglycemia Using the 2015 United States Preventive Services Task Force Screening Criteria: A Cohort Analysis of Community Health Center Patients.
title_short Detecting Dysglycemia Using the 2015 United States Preventive Services Task Force Screening Criteria: A Cohort Analysis of Community Health Center Patients.
title_sort detecting dysglycemia using the 2015 united states preventive services task force screening criteria a cohort analysis of community health center patients
url https://journals.plos.org/plosmedicine/article/file?id=10.1371/journal.pmed.1002074&type=printable
work_keys_str_mv AT matthewjobrien detectingdysglycemiausingthe2015unitedstatespreventiveservicestaskforcescreeningcriteriaacohortanalysisofcommunityhealthcenterpatients
AT jiyounglee detectingdysglycemiausingthe2015unitedstatespreventiveservicestaskforcescreeningcriteriaacohortanalysisofcommunityhealthcenterpatients
AT mercedesrcarnethon detectingdysglycemiausingthe2015unitedstatespreventiveservicestaskforcescreeningcriteriaacohortanalysisofcommunityhealthcenterpatients
AT ronaldtackermann detectingdysglycemiausingthe2015unitedstatespreventiveservicestaskforcescreeningcriteriaacohortanalysisofcommunityhealthcenterpatients
AT mariacvargas detectingdysglycemiausingthe2015unitedstatespreventiveservicestaskforcescreeningcriteriaacohortanalysisofcommunityhealthcenterpatients
AT andrewhamilton detectingdysglycemiausingthe2015unitedstatespreventiveservicestaskforcescreeningcriteriaacohortanalysisofcommunityhealthcenterpatients
AT niveditamohanty detectingdysglycemiausingthe2015unitedstatespreventiveservicestaskforcescreeningcriteriaacohortanalysisofcommunityhealthcenterpatients
AT sarahsrittner detectingdysglycemiausingthe2015unitedstatespreventiveservicestaskforcescreeningcriteriaacohortanalysisofcommunityhealthcenterpatients
AT jessicanpark detectingdysglycemiausingthe2015unitedstatespreventiveservicestaskforcescreeningcriteriaacohortanalysisofcommunityhealthcenterpatients
AT amrohassan detectingdysglycemiausingthe2015unitedstatespreventiveservicestaskforcescreeningcriteriaacohortanalysisofcommunityhealthcenterpatients
AT davidrbuchanan detectingdysglycemiausingthe2015unitedstatespreventiveservicestaskforcescreeningcriteriaacohortanalysisofcommunityhealthcenterpatients
AT leiliu detectingdysglycemiausingthe2015unitedstatespreventiveservicestaskforcescreeningcriteriaacohortanalysisofcommunityhealthcenterpatients
AT josephfeinglass detectingdysglycemiausingthe2015unitedstatespreventiveservicestaskforcescreeningcriteriaacohortanalysisofcommunityhealthcenterpatients